Physician

David J Rodak, M.D.

According to 2025 Medicare claims, David Rodak, M.D. (NPI: 1215983887) practices cardiac electrophysiology in the Spartanburg, SC market, with the plurality of this provider's patient population coming from Spartanburg, SC. This provider's primary affiliated billing organization is SPARTANBURG MEDICAL CENTER (NPI: 1013781400; TIN: 57-6000934) and primary practice location at 29303-2248. Rodak is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Rodak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,332 traditional Medicare patients, billed 8,103 HCPCS/CPT codes, and received $415,249 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,153 prescription claims across 1,258 beneficiaries totaling $2,090,539 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 11 claims. Open Payments data shows 168 records totaling $6,223. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $722,100 to $2,090,539. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $20,720 and ending at $15,382.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,992	10,082	$525,817
2016	2,510	8,866	$476,222
2017	2,250	9,177	$467,012
2018	1,973	8,083	$472,262
2019	2,044	9,097	$510,337
2020	1,815	9,092	$474,463
2021	1,727	8,618	$480,548
2022	1,578	8,311	$422,568
2023	1,835	10,808	$545,610
2024	1,332	8,103	$415,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	997	10,027	$722,100
2016	1,024	9,837	$819,153
2017	1,042	9,890	$879,635
2018	1,077	9,540	$1,070,168
2019	1,080	8,281	$1,180,306
2020	1,068	7,559	$1,336,735
2021	1,049	7,364	$1,453,830
2022	1,139	7,156	$1,608,746
2023	1,252	7,926	$1,988,000
2024	1,258	8,153	$2,090,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$20,207
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	256	262	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	396	446	$88
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	423	1,292	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	518	1,507	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	459	561	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,134	63,940	$1,219,780
Xarelto	Rivaroxaban	297	17,826	$322,353
Entresto	Sacubitril/Valsartan	180	9,475	$192,941
Jardiance	Empagliflozin	105	5,193	$98,135
Farxiga	Dapagliflozin Propanediol	57	2,430	$44,107

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	144	$3,162	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	24	$3,062	BIOTRONIK INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David J. Rodak, M.D.?

Tedicare shows public-source Medicare data for David J. Rodak, M.D. (NPI 1215983887), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David J. Rodak, M.D. have ACO affiliation data?

David J. Rodak, M.D. is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to David J. Rodak, M.D.?

David J. Rodak, M.D. is linked to SPARTANBURG MEDICAL CENTER (billing NPI 1013781400) in the available physician profile data.

Does David J. Rodak, M.D. have Open Payments data?

David J. Rodak, M.D. has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.